These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6891927)

  • 1. A multicentre phase II trial of vindesine in malignant melanoma.
    Carmichael J; Atkinson RJ; Calman KC; Mackie RM; Naysmith AM; Smyth JF
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1293-5. PubMed ID: 6891927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vindesine in advanced breast cancer, lymphoma and melanoma. A Colorado Clinical Oncology Group study.
    DiBella NJ; Berris R; Garfield D; Fink K; Speer J; Sakamoto A
    Invest New Drugs; 1984; 2(3):323-8. PubMed ID: 6511238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin and vindesine combination chemotherapy in advanced malignant melanoma: an EORTC phase II study.
    Mulder JH; Dodion P; Cavalli F; Czarnetzki B; Clavel M; Thomas D; Suciu S; Rozencweig M
    Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1297-301. PubMed ID: 6891928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vindesine as a single agent in the treatment of advanced malignant melanoma.
    Retsas S; Newton KA; Westbury G
    Cancer Chemother Pharmacol; 1979; 2(4):257-60. PubMed ID: 455584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of vindesine in metastatic malignant melanoma.
    Arseneau JC; Mellette SJ; Kuperminc M; Wolter J
    Cancer Treat Rep; 1981; 65(3-4):355-6. PubMed ID: 7237458
    [No Abstract]   [Full Text] [Related]  

  • 6. Vindesine for metastatic malignant melanoma. A phase II trial.
    Nelimark RA; Peterson BA; Vosika GJ; Conroy JA
    Am J Clin Oncol; 1983 Oct; 6(5):561-4. PubMed ID: 6613921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update results of vindesine as a single agent in the therapy of advanced malignant melanoma.
    Retsas S; Peat I; Ashford R; Coe M; Maher J; Drury A; Hanham IW; Phillips RH; Newton KA; Westbury G
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():87-90. PubMed ID: 7438128
    [No Abstract]   [Full Text] [Related]  

  • 8. EORTC phase II trial of vindesine in advanced melanoma.
    Rümke P; Everall JD; Mulder JH; Rozencweig M; Czarnetzki B; Thomas D
    Eur J Cancer Clin Oncol; 1983 Aug; 19(8):1173-4. PubMed ID: 6684562
    [No Abstract]   [Full Text] [Related]  

  • 9. Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study.
    Quagliana JM; Stephens RL; Baker LH; Costanzi JJ
    J Clin Oncol; 1984 Apr; 2(4):316-9. PubMed ID: 6707719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of vindesine in patients with malignant melanoma.
    Camacho FJ; Young CW; Wittes RE
    Cancer Treat Rep; 1980 Jan; 64(1):179-81. PubMed ID: 7379054
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of vindesine in advanced head and neck cancer.
    Cheng E; Young CW; Wittes RE
    Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An EORTC phase II study of vindesine in advanced prostate cancer.
    Jones WG; Fosså SD; Denis L; Coninx P; Glashan RW; Akdas A; De Pauw M
    Eur J Cancer Clin Oncol; 1983 May; 19(5):583-8. PubMed ID: 6683629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.
    Mayol XF; Beltran J; Rubio-Bazan R; Rifa J; Costa RR; Lopez JJ
    Cancer Treat Rep; 1984 Sep; 68(9):1199-200. PubMed ID: 6444204
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II evaluation of vindesine in patients with advanced breast cancer.
    Currie VE; Camacho F; Wittes R; Young C
    Cancer Treat Rep; 1980; 64(4-5):693-95. PubMed ID: 7427954
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanoma.
    Retsas S; Thomas C; Hobbs JR
    Clin Oncol; 1981 Mar; 7(1):33-7. PubMed ID: 7214761
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phase II study of vindesine in hematological malignancies].
    Gan To Kagaku Ryoho; 1983 Dec; 10(12):2509-15. PubMed ID: 6580841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad phase II study of vindesine.
    Valdivieso M; Bedikian AY; Bodey GP; Freireich EJ
    Cancer Treat Rep; 1981; 65(9-10):877-9. PubMed ID: 7273021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phase II study of vindesine in patients with primary bronchogenic carcinoma by Cooperative Study Group].
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1838-43. PubMed ID: 6882007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of vindesine in advanced neoplastic disease.
    Stambaugh JE
    Cancer Treat Rev; 1980 Sep; 7 Suppl 1():75-9. PubMed ID: 7438126
    [No Abstract]   [Full Text] [Related]  

  • 20. Vindesine in the treatment of refractory hematologic malignancies: a phase II study.
    Mandelli F; Amadori S; Giona F; Antonietta M; Spiriti A; Pastore S; Meloni G; Paolucci G
    Leuk Res; 1982; 6(5):649-52. PubMed ID: 7154707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.